Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNecmettin Erbakan University

About this trial

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being diagnosed with stage 4 (group D) COPD according to GOLD criteria

Being 18 years or older,

Having a video computer, tablet or phone,

Having an internet connection at home or on the phone,

Disqualifiers

Being illiterate,

Being diagnosed with first, second and third-stage COPD according to GOLD criteria,

Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.),

Having physical and/or mental disabilities,

Trial design

Design model

Parallel

Treatments tested in this trial

  • health education

    Other intervention

    Health Education: While they are still in the hospital, a 30-minute individually planned education about their disease will be given to patients using the COPD patient education booklet. step 1. Smoking cessation, step 2. Vaccination, step 3. Correct drug use, step 4. Regular exercise, step 5. Healthy eating, step 6. Coping with stress, step 7 Coping with attacks, step 8. Includes regular oxygen therapy. Let's learn nhaverug treatments in coping with COPD, under the title of pulmonary rehabilitation (Respiratory Rehabilitation), methods of coping with shortness of breath, indoor air pollution and outdoor air pollution subheadings.

  • Mobile application (Creating a WhatsApp group):

    Other intervention

    A group will be created through the WhatsApp application for participants in health education and visual and audio materials will be shared through this group every week. In the coming weeks, the researcher will provide consultancy services to those who have problems with the application.

  • Telephone interview:

    Other intervention

    Participants will be called every month by the researcher and asked if there are any hospital visits in that month, especially if they are chest disease visits.

Treatment groups

74 Participants
are divided into 2 treatment groups
Group A: intervention groupExperimental treatment 3 interventions
Group B: Not intervention groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

number of hospital admissions

Number of hospital admissions

Time frame
At the end of the 1st month.
2

number of hospital admissions

Number of hospital admissions

Time frame
At the end of the 3st month.
3

number of hospital admissions

Number of hospital admissions

Time frame
At the end of the 6st month.

Secondary outcomes

1

Scores from the mMRC Dyspnea scale (on the first encounter)

0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope); 1. point for mild dyspnea (difficulty breathing when moving quickly on a flat surface or climbing a gentle slope); 2. points for moderate dyspnea (walks slower than peers when walking on level ground, pauses for breathing); 3. points for severe dyspnea (stopping to breath after walking 100 meters or for a few minutes); and 4 points as very severe dyspnea (shortness of breath while doing daily chores at home, putting on/taking off clothes or going to the toilet). As the score increases, the level of dyspnea also increases.

Time frame
At the end of the 1st month.
2

Scores from the mMRC Dyspnea scale (on the first encounter)

0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope); 1. point for mild dyspnea (difficulty breathing when moving quickly on a flat surface or climbing a gentle slope); 2. points for moderate dyspnea (walks slower than peers when walking on level ground, pauses for breathing); 3. points for severe dyspnea (stopping to breath after walking 100 meters or for a few minutes); and 4 points as very severe dyspnea (shortness of breath while doing daily chores at home, putting on/taking off clothes or going to the toilet). As the score increases, the level of dyspnea also increases.

Time frame
At the end of the 3st month.
3

Scores from the mMRC Dyspnea scale (on the first encounter)

0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope); 1. point for mild dyspnea (difficulty breathing when moving quickly on a flat surface or climbing a gentle slope); 2. points for moderate dyspnea (walks slower than peers when walking on level ground, pauses for breathing); 3. points for severe dyspnea (stopping to breath after walking 100 meters or for a few minutes); and 4 points as very severe dyspnea (shortness of breath while doing daily chores at home, putting on/taking off clothes or going to the toilet). As the score increases, the level of dyspnea also increases.

Time frame
At the end of the 6st month.
4

Scores from the St George Respiratory Questionnaire

The total score that can be obtained from the scale is 0 min. - 100 max. The number zero indicates good health, and the number 100 indicates poor health. The scale is Likert type and the questions are in the form of "yes" and "no". The symptoms section consists of 8 items and is scored in the range of 0-16 points. The activity section consists of 16 items and is scored in the range of 0-32 points. The effects of the disease section consists of 26 items and is scored in the range of 0-52 points.

Time frame
At the end of the 1st month.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.